Loading...
Loading...
Analysts at Goldman Sachs initiated coverage on shares of BioMed Realty Trust
BMR with a “neutral” rating. The target price for BioMed Realty is set to $20. BioMed Realty's shares closed at $20.12 yesterday.
Benchmark initiated coverage on shares of Omnicell
OMCL with a “buy” rating. The target price for Omnicell is set to $19. Omnicell's shares closed at $15.57 yesterday.
Evercore Partners initiated coverage on shares of Accenture plc
ACN with an “overweight” rating. The target price for Accenture is set to $86. Accenture's stock closed at $71.34 yesterday.
Analysts at SunTrust initiated coverage on shares of BioScrip
BIOS with a “buy” rating. The target price for BioScrip is set to $13.50. BioScrip's shares closed at $11.70 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in